Farther Finance Advisors, LLC Exelixis, Inc. Transaction History
Farther Finance Advisors, LLC
- $2.77 Trillion
- Q4 2024
A detailed history of Farther Finance Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 5,065 shares of EXEL stock, worth $184,163. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,065
Previous 3,940
28.55%
Holding current value
$184,163
Previous $102 Million
64.96%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.22 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.07 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$852 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$556 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$415 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...